Oric Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oric Pharmaceuticals, Inc. has filed 405 SEC EDGAR filings since 13 Dec 2019

SEC filing history

Showing 1-5 of 5 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-91490

AMENDMENT NO. 4

Filing date
27 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91490

AMENDMENT NO. 3

Filing date
12 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91490

AMENDMENT NO. 2

Filing date
22 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91490

AMENDMENT NO. 1

Filing date
18 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91490

SCHEDULE 13D

Filing date
01 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .